1. Nouraei SA, Middleton SE, Butler CR, Sandhu GS. An estimation of the population incidence of adult unilateral vocal fold mobility impairment in England. Logoped Phoniatr Vocol. 2015 Jul;40(2):93-4.
2. Jellish WS, Jensen RL, Anderson DE, Shea JF. Intraoperative electromyographic assessment of recurrent laryngeal nerve stress and pharyngeal injury during anterior cervical spine surgery with Caspar instrumentation. J Neurosurg. 1999 Oct;91(2 Suppl):170-4.
3. Pisanu A, Porceddu G, Podda M, Cois A, Uccheddu A. Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy. J Surg Res. 2014 May;188(1):152-61.
4. Crumley RL. Repair of the recurrent laryngeal nerve. Otolaryngol Clin North Am. 1990 Jun;23(3):553-63.
5. Mirza N, Ruiz C, Baum ED, Staab JP. The prevalence of major psychiatric pathologies in patients with voice disorders. Ear Nose Throat J. 2003 Oct;82(10):808-10.
6. Roy N, Merrill RM, Gray SD, Smith EM. Voice disorders in the general population: prevalence, risk factors, and occupational impact. Laryngoscope. 2005 Nov;115(11):1988-95.
7. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. J Voice. 1998 Dec;12(4):540-50.
8. Stachler RJ, Francis DO, Schwartz SR, Damask CC, Digoy GP, Krouse HJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). Otolaryngol Head Neck Surg. 2018 Mar;158(1_suppl):S1-S42.
9. Rosen CA, Mau T, Remacle M, Hess M, Eckel HE, Young VN, et al. Nomenclature proposal to describe vocal fold motion impairment. Eur Arch Otorhinolaryngol. 2016 Aug;273(8):1995-9.
10. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010 Aug;153(3):194-9.
11. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013 Apr;66(4):408-14.
13. Rosow DE, Sulica L. Laryngoscopy of vocal fold paralysis: evaluation of consistency of clinical findings. Laryngoscope. 2010 Jul;120(7):1376-82.
14. Belafsky PC, Postma GN, Reulbach TR, Holland BW, Koufman JA. Muscle tension dysphonia as a sign of underlying glottal insufficiency. Otolaryngol Head Neck Surg. 2002 Nov;127(5):448-51.
15. Heuer RJ, Sataloff RT, Emerich K, Rulnick R, Baroody M, Spiegel JR, et al. Unilateral recurrent laryngeal nerve paralysis: the importance of “preoperative” voice therapy. J Voice. 1997 Mar;11(1):88-94.
16. Miller S. Voice therapy for vocal fold paralysis. Otolaryngol Clin North Am. 2004 Feb;37(1):105-19.
17. Rubin AD, Sataloff RT. Vocal fold paresis and paralysis. Otolaryngol Clin North Am. 2007 Oct;40(5):1109-31.
18. Sellars C, Carding PN, Deary IJ, MacKenzie K, Wilson JA. Characterization of effective primary voice therapy for dysphonia. J Laryngol Otol. 2002 Dec;116(12):1014-8.
19. Woodson GE. Configuration of the glottis in laryngeal paralysis. I: Clinical study. Laryngoscope. 1993 Nov;103(11 Pt 1):1227-34.
20. Hiramatsu H, Tokashiki R, Nakamura M, Motohashi R, Yoshida T, Suzuki M. Characterization of arytenoid vertical displacement in unilateral vocal fold paralysis by three-dimensional computed tomography. Eur Arch Otorhinolaryngol. 2009 Jan;266(1):97-104.
21. Paul BC, Rafii B, Achlatis S, Amin MR, Branski RC. Morbidity and patient perception of flexible laryngoscopy. Ann Otol Rhinol Laryngol. 2012 Nov;121(11):708-13.
22. Grossman M. Experimentelle beitrage zur lehre von der posticuslahmung. Arch Laryngol Rhinol. 1897;(6):282-360.
23. Wagner R. Die medianstellung des stimmbandes bei Recurrenslahmung. Archiv F Pathol Anat. 1890;120:437-9.
24. Behrman A. Evidence-based treatment of paralytic dysphonia: making sense of outcomes and efficacy data. Otolaryngol Clin North Am. 2004 Feb;37(1):75-104.
25. Woo P. Quantification of videostrobolaryngoscopic findings: measurements of the normal glottal cycle. Laryngoscope. 1996 Mar;106(3 Pt 2 Suppl 79):1-27.
26. Sercarz JA, Berke GS, Ming Y, Gerratt BR, Natividad M. Videostroboscopy of human vocal fold paralysis. Ann Otol Rhinol Laryngol. 1992 Jul;101(7):567-77.
28. Harries ML, Morrison M. The role of stroboscopy in the management of a patient with a unilateral vocal fold paralysis. J Laryngol Otol. 1996 Feb;110(2):141-3.
29. Baylor CR, Yorkston KM, Eadie TL, Strand EA, Duffy J. A systematic review of outcome measurement in unilateral vocal fold paralysis. J Med Speech Lang Pathol. 2006 Mar;14(1):xxvii-lvii.
30. Bonilha HS, Focht KL, Martin-Harris B. Rater methodology for stroboscopy: a systematic review. J Voice. 2015 Jan;29(1):101-8.
31. Uloza V, Vegiene A, Saferis V. Correlation between the basic video laryngostroboscopic parameters and multidimensional voice measurements. J Voice. 2013 Nov;27(6):744-52.
32. Dejonckere PH, Bradley P, Clemente P, Cornut G, Crevier-Buchman L, Friedrich G, et al. A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol. 2001 Feb;258(2):77-82.
33. Mattei A, Desuter G, Roux M, Lee BJ, Louges MA, Osipenko E, et al. International consensus (ICON) on basic voice assessment for unilateral vocal fold paralysis. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Feb;135(1S):S11-5.
34. Desuter G, Dedry M, Schaar B, van Lith-Bijl J, van Benthem PP, Sjogren EV. Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature. Eur Arch Otorhinolaryngol. 2018 Feb;275(2):459-68.
35. Walton C, Conway E, Blackshaw H, Carding P. Unilateral vocal fold paralysis: a systematic review of speech-language pathology management. J Voice. 2017 Jul;31(4):509.
36. Walton C, Carding P, Flanagan K. Perspectives on voice treatment for unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. 2018 Jun;26(3):157-61.
37. Balasubramanium RK, Bhat JS, Fahim S 3rd, Raju R 3rd. Cepstral analysis of voice in unilateral adductor vocal fold palsy. J Voice. 2011 May;25(3):326-9.
38. Heman-Ackah YD. Reliability of calculating the cepstral peak without linear regression analysis. J Voice. 2004 Jun;18(2):203-8.
39. Lee CY, Jeong HS, Son HY. Usefulness of cepstral peak prominence (CPP) in unilateral vocal fold paralysis dysphonia evaluation. J Korean Soc Laryngol Phoniatr Logoped. 2017 Dec;28(2):84-8.
40. MacGregor FB, Roberts DN, Howard DJ, Phelps PD. Vocal fold palsy: a re-evaluation of investigations. J Laryngol Otol. 1994 Mar;108(3):193-6.
41. Rosenthal LH, Benninger MS, Deeb RH. Vocal fold immobility: a longitudinal analysis of etiology over 20 years. Laryngoscope. 2007 Oct;117(10):1864-70.
42. Pretorius PM, Milford CA. Investigating the hoarse voice. BMJ. 2008 Oct;337:a1726.
43. Robinson S, Pitkaranta A. Radiology findings in adult patients with vocal fold paralysis. Clin Radiol. 2006 Oct;61(10):863-7.
44. Merati AL, Halum SL, Smith TL. Diagnostic testing for vocal fold paralysis: survey of practice and evidence-based medicine review. Laryngoscope. 2006 Sep;116(9):1539-52.
45. Sataloff RT, Praneetvatakul P, Heuer RJ, Hawkshaw MJ, Heman-Ackah YD, Schneider SM, et al. Laryngeal electromyography: clinical application. J Voice. 2010 Mar;24(2):228-34.
46. Wang CC, Chang MH, De Virgilio A, Jiang RS, Lai HC, Wang CP, et al. Laryngeal electromyography and prognosis of unilateral vocal fold paralysis: a long-term prospective study. Laryngoscope. 2015 Apr;125(4):898-903.
47. Sulica L, Blitzer A. Electromyography and the immobile vocal fold. Otolaryngol Clin North Am. 2004 Feb;37(1):59-74.
48. Heman-Ackah YD, Barr A. The value of laryngeal electromyography in the evaluation of laryngeal motion abnormalities. J Voice. 2006 Sep;20(3):452-60.
49. Focquet A, Pereon Y, Segura S, Ferron C, Malard O, Espitalier F. Diagnostic and prognostic contribution of laryngeal electromyography in unilateral vocal-fold immobility in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Feb;134(1):13-8.
50. Volk GF, Hagen R, Pototschnig C, Friedrich G, Nawka T, Arens C, et al. Laryngeal electromyography: a proposal for guidelines of the European Laryngological Society. Eur Arch Otorhinolaryngol. 2012 Oct;269(10):2227-45.
51. Woo P, Isseroff TF, Parasher A, Richards A, Sivak M. Laryngeal Electromyographic findings in patients with vocal fold motion asymmetry. Laryngoscope. 2016 Aug;126(8):E273-7.
52. Wang CC, Chang MH, Jiang RS, Lai HC, De Virgilio A, Wang CP, et al. Laryngeal electromyography-guided hyaluronic acid vocal fold injection for unilateral vocal fold paralysis: a prospective long-term follow-up outcome report. JAMA Otolaryngol Head Neck Surg. 2015 Mar;141(3):264-71.
53. Wang CC, Chang MH, Wang CP, Liu SA. Prognostic indicators of unilateral vocal fold paralysis. Arch Otolaryngol Head Neck Surg. 2008 Apr;134(4):380-8.
54. Munin MC, Heman-Ackah YD, Rosen CA, Sulica L, Maronian N, Mandel S, et al. Consensus statement: Using laryngeal electromyography for the diagnosis and treatment of vocal cord paralysis. Muscle Nerve. 2016 Jun;53(6):850-5.
55. Rickert SM, Childs LF, Carey BT, Murry T, Sulica L. Laryngeal electromyography for prognosis of vocal fold palsy: a meta-analysis. Laryngoscope. 2012 Jan;122(1):158-61.
56. Parnes SM, Satya-Murti S. Predictive value of laryngeal electromyography in patients with vocal cord paralysis of neurogenic origin. Laryngoscope. 1985 Nov;95(11):1323-6.
58. Sunderland S. A classification of peripheral nerve injuries producing loss of function. Brain. 1951 Dec;74(4):491-516.
59. Chen D, Chen S, Wang W, Zhang C, Zheng H. Spontaneous regeneration of recurrent laryngeal nerve following long-term vocal fold paralysis in humans: histologic evidence. Laryngoscope. 2011 May;121(5):1035-9.
60. Mattsson P, Hydman J, Svensson M. Recovery of laryngeal function after intraoperative injury to the recurrent laryngeal nerve. Gland Surg. 2015 Feb;4(1):27-35.
61. Woodson GE. Spontaneous laryngeal reinnervation after recurrent laryngeal or vagus nerve injury. Ann Otol Rhinol Laryngol. 2007 Jan;116(1):57-65.
62. Sulica L. The natural history of idiopathic unilateral vocal fold paralysis: evidence and problems. Laryngoscope. 2008 Jul;118(7):1303-7.
63. Husain S, Sadoughi B, Mor N, Levin AM, Sulica L. Time course of recovery of idiopathic vocal fold paralysis. Laryngoscope. 2018 Jan;128(1):148-52.
64. Mau T, Pan HM, Childs LF. The natural history of recoverable vocal fold paralysis: implications for kinetics of reinnervation. Laryngoscope. 2017 Nov;127(11):2585-90.
65. Cohen SM, Lee HJ, Roy N, Misono S. Pharmacologic management of voice disorders by general medicine providers and otolaryngologists. Laryngoscope. 2018 Mar;128(3):682-9.
67. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012 Mar;146(3 Suppl):S1-35.
68. Wang LF, Lee KW, Kuo WR, Wu CW, Lu SP, Chiang FY. The efficacy of intraoperative corticosteroids in recurrent laryngeal nerve palsy after thyroid surgery. World J Surg. 2006 Mar;30(3):299-303.
69. Cheng SP, Liu TP, Yang PS, Lee KS, Liu CL. Effect of perioperative dexamethasone on subjective voice quality after thyroidectomy: a meta-analysis and systematic review. Langenbecks Arch Surg. 2015 Dec;400(8):929-36.
70. Benninger MS. Acyclovir for the treatment of idiopathic vocal fold paralysis. Ear Nose Throat J. 1992 May;71(5):207-8.
71. Coleman C, Fozo M, Rubin A. Ramsay Hunt syndrome with severe dysphagia. J Voice. 2012 Jan;26(1):e27-8.
73. Ichimura H, Ishikawa S, Yamamoto T, Onizuka M, Inadome Y, Noguchi M, et al. Effectiveness of steroid treatment for hoarseness caused by idiopathic fibrosing mediastinitis: report of a case. Surg Today. 2006;36(4):382-4.
74. Kwon TK, Buckmire R. Injection laryngoplasty for management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. 2004 Dec;12(6):538-42.
75. Tamura E, Fukuda H, Tabata Y. Intracordal injection technique: materials and injection site. Tokai J Exp Clin Med. 2008 Sep;33(3):119-23.
76. Verma SP, Dailey SH. Office-based injection laryngoplasty for the management of unilateral vocal fold paralysis. J Voice. 2014 May;28(3):382-6.
77. Dahlqvist A, Garskog O, Laurent C, Hertegard S, Ambrosio L, Borzacchiello A. Viscoelasticity of rabbit vocal folds after injection augmentation. Laryngoscope. 2004 Jan;114(1):138-42.
78. Arron ST, Neuhaus IM. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid. J Cosmet Dermatol. 2007 Sep;6(3):167-71.
79. Hertegard S, Hallen L, Laurent C, Lindstrom E, Olofsson K, Testad P, et al. Cross-linked hyaluronan versus collagen for injection treatment of glottal insufficiency: 2-year follow-up. Acta Otolaryngol. 2004 Dec;124(10):1208-14.
80. Molteni G, Bergamini G, Ricci-Maccarini A, Marchese C, Ghidini A, Alicandri-Ciufelli M, et al. Auto-crosslinked hyaluronan gel injections in phonosurgery. Otolaryngol Head Neck Surg. 2010 Apr;142(4):547-53.
82. Kamer FM, Churukian MM. Clinical use of injectable collagen: a three-year retrospective review. Arch Otolaryngol. 1984 Feb;110(2):93-8.
83. Bentkover SH. The biology of facial fillers. Facial Plast Surg. 2009 May;25(2):73-85.
84. Milstein CF, Akst LM, Hicks MD, Abelson TI, Strome M. Long-term effects of micronized Alloderm injection for unilateral vocal fold paralysis. Laryngoscope. 2005 Sep;115(9):1691-6.
85. Tan M, Woo P. Injection laryngoplasty with micronized dermis: a 10-year experience with 381 injections in 344 patients. Laryngoscope. 2010 Dec;120(12):2460-6.
86. Chhetri DK, Jahan-Parwar B, Hart SD, Bhuta SM, Berke GS. Injection laryngoplasty with calcium hydroxylapatite gel implant in an in vivo canine model. Ann Otol Rhinol Laryngol. 2004 Apr;113(4):259-64.
87. Rosen CA, Gartner-Schmidt J, Casiano R, Anderson TD, Johnson F, Remacle M, et al. Vocal fold augmentation with calcium hydroxylapatite: twelve-month report. Laryngoscope. 2009 May;119(5):1033-41.
88. Carroll TL, Rosen CA. Long-term results of calcium hydroxylapatite for vocal fold augmentation. Laryngoscope. 2011 Feb;121(2):313-9.
89. Tanna N, Zalkind D, Glade RS, Bielamowicz SA. Foreign body reaction to calcium hydroxylapatite vocal fold augmentation. Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1379-82.
91. Min JY, Hong SD, Kim K, Son YI. Long-term results of Artecoll injection laryngoplasty for patients with unilateral vocal fold motion impairment: safety and clinical efficacy. Arch Otolaryngol Head Neck Surg. 2008 May;134(5):490-6.
92. Sulica L, Rosen CA, Postma GN, Simpson B, Amin M, Courey M, et al. Current practice in injection augmentation of the vocal folds: indications, treatment principles, techniques, and complications. Laryngoscope. 2010 Feb;120(2):319-25.
93. Mathison CC, Villari CR, Klein AM, Johns MM 3rd. Comparison of outcomes and complications between awake and asleep injection laryngoplasty: a case-control study. Laryngoscope. 2009 Jul;119(7):1417-23.
94. Young VN, Smith LJ, Sulica L, Krishna P, Rosen CA. Patient tolerance of awake, in-office laryngeal procedures: a multi-institutional perspective. Laryngoscope. 2012 Feb;122(2):315-21.
95. Costello D. Change to earlier surgical interventions: contemporary management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. 2015 Jun;23(3):181-4.
96. Soriano RG, Pei YC, Fang TJ. In-office hyaluronate injection laryngoplasty as palliative treatment for unilateral vocal fold paralysis. ORL J Otorhinolaryngol Relat Spec. 2016;78(4):187-92.
97. Chun BJ, Shim MR, Hwang YS, Joo YH, Park YH, Sun DI. The usefulness of the transcricothyroid injection laryngoplasty via contralateral paramedian approach. Auris Nasus Larynx. 2017 Feb;44(1):93-7.
98. Woo SH, Son YI, Lee SH, Park JJ, Kim JP. Comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach. J Voice. 2013 Mar;27(2):236-41.
99. Tirado Y, Lewin JS, Hutcheson KA, Kupferman ME. Office-based injection laryngoplasty in the irradiated larynx. Laryngoscope. 2010 Apr;120(4):703-6.
100. Graboyes EM, Bradley JP, Meyers BF, Nussenbaum B. Efficacy and safety of acute injection laryngoplasty for vocal cord paralysis following thoracic surgery. Laryngoscope. 2011 Nov;121(11):2406-10.
101. Vila PM, Bhatt NK, Paniello RC. Early-injection laryngoplasty may lower risk of thyroplasty: a systematic review and meta-analysis. Laryngoscope. 2018 Apr;128(4):935-40.
102. Pei YC, Fang TJ, Hsin LJ, Li HY, Wong AM. Early hyaluronate injection improves quality of life but not neural recovery in unilateral vocal fold paralysis: an open-label randomized controlled study. Restor Neurol Neurosci. 2015;33(2):121-30.
103. Powell J, Carding P, Birdi R, Wilson JA. Injection laryngoplasty in the outpatient clinic under local anaesthetic: a case series of sixty-eight patients. Clin Otolaryngol. 2014 Aug;39(4):224-7.
104. Rosen CA. Complications of phonosurgery: results of a national survey. Laryngoscope. 1998 Nov;108(11 Pt 1):1697-703.
105. Mohammed H, Masterson L, Gendy S, Nassif R. Outpatient-based injection laryngoplasty for the management of unilateral vocal fold paralysis: clinical outcomes from a UK centre. Clin Otolaryngol. 2016 Aug;41(4):341-6.
106. Anderson TD, Sataloff RT. Complications of collagen injection of the vocal fold: report of several unusual cases and review of the literature. J Voice. 2004 Sep;18(3):392-7.
107. DeFatta RA, Chowdhury FR, Sataloff RT. Complications of injection laryngoplasty using calcium hydroxylapatite. J Voice. 2012 Sep;26(5):614-8.
109. Fang TJ, Pei YC, Li HY, Wong AM, Chiang HC. Glottal gap as an early predictor for permanent laryngoplasty in unilateral vocal fold paralysis. Laryngoscope. 2014 Sep;124(9):2125-30.
110. Friedman AD, Burns JA, Heaton JT, Zeitels SM. Early versus late injection medialization for unilateral vocal cord paralysis. Laryngoscope. 2010 Oct;120(10):2042-6.
111. Halderman AA, Bryson PC, Benninger MS, Chota R. Safety and length of benefit of restylane for office-based injection medialization-a retrospective review of one institution’s experience. J Voice. 2014 Sep;28(5):631-5.
112. Prendes BL, Yung KC, Likhterov I, Schneider SL, Al-Jurf SA, Courey MS. Long-term effects of injection laryngoplasty with a temporary agent on voice quality and vocal fold position. Laryngoscope. 2012 Oct;122(10):2227-33.
113. Yung KC, Likhterov I, Courey MS. Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients. Laryngoscope. 2011 Oct;121(10):2191-4.
114. Brandenburg JH, Kirkham W, Koschkee D. Vocal cord augmentation with autogenous fat. Laryngoscope. 1992 May;102(5):495-500.
115. Kwon TK, An SY, Ahn JC, Kim KH, Sung MW. Calcium hydroxylapatite injection laryngoplasty for the treatment of presbylaryngis: long-term results. Laryngoscope. 2010 Feb;120(2):326-9.
116. Pagano R, Morsomme D, Camby S, Lejeune L, Finck C. Long-term results of 18 fat injections in unilateral vocal fold paralysis. J Voice. 2017 Jul;31(4):505.
117. Rosen CA, Thekdi AA. Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results. J Voice. 2004 Sep;18(3):387-91.
118. Trask DK, Shellenberger DL, Hoffman HT. Transnasal, endoscopic vocal fold augmentation. Laryngoscope. 2005 Dec;115(12):2262-5.
120. Andrews BT, Van Daele DJ, Karnell MP, McCulloch TM, Graham SM, Hoffman HT. Evaluation of open approach and injection laryngoplasty in revision thyroplasty procedures. Otolaryngol Head Neck Surg. 2008 Feb;138(2):226-32.
121. Shen T, Damrose EJ, Morzaria S. A meta-analysis of voice outcome comparing calcium hydroxylapatite injection laryngoplasty to silicone thyroplasty. Otolaryngol Head Neck Surg. 2013 Feb;148(2):197-208.
122. Siu J, Tam S, Fung K. A comparison of outcomes in interventions for unilateral vocal fold paralysis: a systematic review. Laryngoscope. 2016 Jul;126(7):1616-24.
123. Cantillo-Banos E, Jurado-Ramos A, Gutierrez-Jodas J, Ariza-Vargas L. Vocal fold insufficiency: medialization laryngoplasty vs calcium hydroxylapatite microspheres (Radiesse Voice®). Acta Otolaryngol. 2013 Mar;133(3):270-5.
124. Umeno H, Chitose S, Sato K, Ueda Y, Nakashima T. Long-term postoperative vocal function after thyroplasty type I and fat injection laryngoplasty. Ann Otol Rhinol Laryngol. 2012 Mar;121(3):185-91.
125. Umeno H, Chitose S, Sato K, Nakashima T. Comparative study of framework surgery and fat injection laryngoplasty. J Laryngol Otol Suppl. 2009;35-41.
126. Abraham MT, Gonen M, Kraus DH. Complications of type I thyroplasty and arytenoid adduction. Laryngoscope. 2001 Aug;111(8):1322-9.
127. Kwon M, Choi SH. Transoral arytenoid adduction with minimal cervical incision. Laryngoscope. 2015 May;125(5):1172-4.
128. Murata T, Yasuoka Y, Shimada T, Shino M, Iida H, Takahashi K, et al. A new and less invasive procedure for arytenoid adduction surgery: endoscopic-assisted arytenoid adduction surgery. Laryngoscope. 2011 Jun;121(6):1274-80.
129. Young VN, Zullo TG, Rosen CA. Analysis of laryngeal framework surgery: 10-year follow-up to a national survey. Laryngoscope. 2010 Aug;120(8):1602-8.
132. Isshiki N, Okamura H, Ishikawa T. Thyroplasty type I (lateral compression) for dysphonia due to vocal cord paralysis or atrophy. Acta Otolaryngol. 1975 Nov-Dec;80(5-6):465-73.
133. Isshiki N, Tanabe M, Sawada M. Arytenoid adduction for unilateral vocal cord paralysis. Arch Otolaryngol. 1978 Oct;104(10):555-8.
134. Chester MW, Stewart MG. Arytenoid adduction combined with medialization thyroplasty: an evidence-based review. Otolaryngol Head Neck Surg. 2003 Oct;129(4):305-10.
135. Hess MM, Fleischer S. Laryngeal framework surgery: current strategies. Curr Opin Otolaryngol Head Neck Surg. 2016 Dec;24(6):505-9.
136. Li AJ, Johns MM, Jackson-Menaldi C, Dailey S, Heman-Ackah Y, Merati A, et al. Glottic closure patterns: type I thyroplasty versus type I thyroplasty with arytenoid adduction. J Voice. 2011 May;25(3):259-64.
137. Mortensen M, Carroll L, Woo P. Arytenoid adduction with medialization laryngoplasty versus injection or medialization laryngoplasty: the role of the arytenoidopexy. Laryngoscope. 2009 Apr;119(4):827-31.
138. Chang J, Schneider SL, Curtis J, Langenstein J, Courey MS, Yung KC. Outcomes of medialization laryngoplasty with and without arytenoid adduction. Laryngoscope. 2017 Nov;127(11):2591-5.
139. Kumai Y, Kodama N, Murakami D, Yumoto E. Comparison of vocal outcome following two different procedures for immediate RLN reconstruction. Eur Arch Otorhinolaryngol. 2016 Apr;273(4):967-72.
140. Chou FF, Su CY, Jeng SF, Hsu KL, Lu KY. Neurorrhaphy of the recurrent laryngeal nerve. J Am Coll Surg. 2003 Jul;197(1):52-7.
141. Lee SW, Park KN, Oh SK, Jung CH, Mok JO, Kim CH. Long-term efficacy of primary intraoperative recurrent laryngeal nerve reinnervation in the management of thyroidectomy-related unilateral vocal fold paralysis. Acta Otolaryngol. 2014 Nov;134(11):1179-84.
142. Lee SW, Park KN. A long-term comparative prospective study between reinnervation and injection laryngoplasty. Laryngoscope. 2018 Aug;128(8):1893-7.
143. Lorenz RR, Esclamado RM, Teker AM, Strome M, Scharpf J, Hicks D, et al. Ansa cervicalis-to-recurrent laryngeal nerve anastomosis for unilateral vocal fold paralysis: experience of a single institution. Ann Otol Rhinol Laryngol. 2008 Jan;117(1):40-5.
144. Yumoto E, Sanuki T, Kumai Y. Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope. 2006 Sep;116(9):1657-61.
145. Aynehchi BB, McCoul ED, Sundaram K. Systematic review of laryngeal reinnervation techniques. Otolaryngol Head Neck Surg. 2010 Dec;143(6):749-59.
146. Miyauchi A, Yokozawa T, Kobayashi K, Hirai K, Matsuzuka F, Kuma K. Opposite ansa cervicalis to recurrent laryngeal nerve anastomosis to restore phonation in patients with advanced thyroid cancer. Eur J Surg. 2001 Jul;167(7):540-1.
147. Paniello RC. Laryngeal reinnervation. Otolaryngol Clin North Am. 2004 Feb;37(1):161-81.
148. Crumley RL. Laryngeal synkinesis revisited. Ann Otol Rhinol Laryngol. 2000 Apr;109(4):365-71.
149. Kelchner LN, Lee L, Stemple JC. Laryngeal function and vocal fatigue after prolonged reading in individuals with unilateral vocal fold paralysis. J Voice. 2003 Dec;17(4):513-28.
150. Schneider B, Schickinger-Fischer B, Zumtobel M, Mancusi G, Bigenzahn W, Klepetko W, et al. Concept for diagnosis and therapy of unilateral recurrent laryngeal nerve paralysis following thoracic surgery. Thorac Cardiovasc Surg. 2003 Dec;51(6):327-31.
151. Aronson AE. Clinical voice disorders. New York: Thieme Medical Publishers; 1990.
152. Kao YC, Chen SH, Wang YT, Chu PY, Tan CT, Chang WD. Efficacy of voice therapy for patients with early unilateral adductor vocal fold paralysis. J Voice. 2017 Sep;31(5):567-75.
153. Mattioli F, Menichetti M, Bergamini G, Molteni G, Alberici MP, Luppi MP, et al. Results of early versus intermediate or delayed voice therapy in patients with unilateral vocal fold paralysis: our experience in 171 patients. J Voice. 2015 Jul;29(4):455-8.
154. Schindler A, Bottero A, Capaccio P, Ginocchio D, Adorni F, Ottaviani F. Vocal improvement after voice therapy in unilateral vocal fold paralysis. J Voice. 2008 Jan;22(1):113-8.
155. Lee CY, An SY, Chang H, Son HY. Comparison of initial therapeutic effects of voice therapy and injection laryngoplasty for unilateral vocal cord paralysis patients. J Korean Soc Laryngol Phoniatr Logoped. 2017 Dec;28(2):112-7.
156. Roy N, Gray SD, Simon M, Dove H, Corbin-Lewis K, Stemple JC. An evaluation of the effects of two treatment approaches for teachers with voice disorders: a prospective randomized clinical trial. J Speech Lang Hear Res. 2001 Apr;44(2):286-96.
157. Sabol JW, Lee L, Stemple JC. The value of vocal function exercises in the practice regimen of singers. J Voice. 1995 Mar;9(1):27-36.
158. Stemple JC, Lee L, D’Amico B, Pickup B. Efficacy of vocal function exercises as a method of improving voice production. J Voice. 1994 Sep;8(3):271-8.
159. Isshiki N. Mechanical and dynamic aspects of voice production as related to voice therapy and phonosurgery. Otolaryngol Head Neck Surg. 2000 Jun;122(6):782-93.
160. Isshiki N. Mechanical and dynamic aspects of voice production as related to voice therapy and phonosurgery. J Voice. 1998 Jun;12(2):125-37.
161. Bailey EF, Hoit JD. Speaking and breathing in high respiratory drive. J Speech Lang Hear Res. 2002 Feb;45(1):89-99.
162. MacLarnon AM, Hewitt GP. The evolution of human speech: the role of enhanced breathing control. Am J Phys Anthropol. 1999 Jul;109(3):341-63.
163. Russell BA, Cerny FJ, Stathopoulos ET. Effects of varied vocal intensity on ventilation and energy expenditure in women and men. J Speech Lang Hear Res. 1998 Apr;41(2):239-48.
164. Verdolini K, Druker DG, Palmer PM, Samawi H. Laryngeal adduction in resonant voice. J Voice. 1998 Sep;12(3):315-27.
165. Yamaguchi H, Yotsukura Y, Sata H, Watanabe Y, Hirose H, Kobayashi N, et al. Pushing exercise program to correct glottal incompetence. J Voice. 1993 Sep;7(3):250-6.
166. Speyer R. Effects of voice therapy: a systematic review. J Voice. 2008 Sep;22(5):565-80.
167. Damrose EJ. Percutaneous injection laryngoplasty in the management of acute vocal fold paralysis. Laryngoscope. 2010 Aug;120(8):1582-90.
168. Bhattacharyya N, Kotz T, Shapiro J. Dysphagia and aspiration with unilateral vocal cord immobility: incidence, characterization, and response to surgical treatment. Ann Otol Rhinol Laryngol. 2002 Aug;111(8):672-9.
169. Carrau RL, Pou A, Eibling DE, Murry T, Ferguson BJ. Laryngeal framework surgery for the management of aspiration. Head Neck. 1999 Mar;21(2):139-45.
170. Flint PW, Purcell LL, Cummings CW. Pathophysiology and indications for medialization thyroplasty in patients with dysphagia and aspiration. Otolaryngol Head Neck Surg. 1997 Mar;116(3):349-54.